单中心跨数十年恶性头颈部副神经节瘤的特征分析
这项回顾性队列研究分析了1963年至2018年间在一家学术性三级癌症医院诊断的70例副神经节瘤患者,其中头颈部副神经节瘤患者中恶性者占9%。恶性头颈部副神经节瘤患者中除1例外均携带SDHB突变,所有恶性患者均接受手术,4例在选择性颈淋巴结清扫时发现转移。作者认为在肿瘤切除时进行选择性颈淋巴结清扫可能有益。
要点
- 恶性头颈部副神经节瘤患病率为9%,诊断困难,通常通过区域或远处转移确定。
- 恶性头颈部副神经节瘤患者中83%(5/6)携带SDHB突变。
- 所有恶性患者均接受手术,4例在选择性颈淋巴结清扫时发现转移。
核心结论
- 恶性头颈部副神经节瘤罕见且难以诊断,通常通过区域或远处转移确定;本研究患病率为9%。
- 数据提示在肿瘤切除时进行选择性颈淋巴结清扫可能有益。
- 除1例外所有恶性头颈部副神经节瘤患者均携带SDHB突变。
研究设计与样本
- 回顾性队列研究,纳入1963年至2018年间在一家学术性三级癌症医院诊断的70例副神经节瘤患者,并对头颈部副神经节瘤进行亚组分析。
- 数据回顾时间为2017年2月至2018年3月。
主要发现
- 70例患者中40例(57%)为男性,平均(SD)年龄47(21.1)岁。
- 头颈部肿瘤患者中38例(54%)为良性,与SDHB突变(18例,47%)、SDHC突变(2例,5%)、SDHD突变(18例,47%)相关。
- 恶性头颈部副神经节瘤患者中除1例外均携带SDHB突变(5例,83%),1例无相关突变。
- 恶性头颈部副神经节瘤平均诊断年龄35岁,良性肿瘤平均诊断年龄36岁。
- 所有恶性患者均接受手术,4例在选择性颈淋巴结清扫时发现转移;5例(83%)接受辅助放疗,1例(17%)接受辅助化疗。
关键数值与推荐
- 恶性头颈部副神经节瘤患病率为9%。
- 良性头颈部副神经节瘤中SDHB突变18例(47%)、SDHC突变2例(5%)、SDHD突变18例(47%)。
- 恶性头颈部副神经节瘤中SDHB突变5例(83%),无突变1例(17%)。
临床怎么用
- 作者认为在肿瘤切除时进行选择性颈淋巴结清扫可能有益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Malignant head and neck paragangliomas (HNPGLs) are rare entities, and there are limited data regarding optimal treatment recommendations to improve clinical outcomes. OBJECTIVE: To classify succinate dehydrogenase (SDH) germline mutations associated with malignant HNPGLs, evaluate time from diagnosis to identification of malignant tumor, describe locations of metastases and the functional status of malignant HNPGLs, and determine the role of selective neck dissection at the time of initial surgical resection. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort study was completed of patients diagnosed with paragangliomas on various sites on the body at an academic tertiary cancer hospital between the years 1963 and 2018. A subanalysis of HNPGLs was also completed. Data regarding diagnosis, gene and mutation, tumor characteristics and location, and treatments used were reviewed between February 2017 and March 2018. MAIN OUTCOMES AND MEASURES: Mutations of SDH genes associated with benign and malignant HNPGLs, treatments used, time to the discovery of malignancy, and location of metastasis. RESULTS: Of the 70 patients included in the study, 40 (57%) were male, and the mean (SD) age was 47 (21.1) years. Of patients with tumors isolated to the head and neck, 38 (54%) had benign HNPGLs, which were associated with mutations in the genes SDH subunit B (SDHB) (n = 18; 47%), SDH subunit C (n = 2; 5%), and SDH subunit D (n = 18; 47%). Among those with malignant HNPGLs, all but 1 patient had mutations in SDHB (n = 5; 83%); 1 patient had no mutation associated with their disease. The average age at diagnosis for malignant HNPGLs was 35 years, while benign tumors were diagnosed at an average age at 36 years. All patients with malignant disease underwent surgery. Four patients were found to have metastasis at the time of selective neck dissection. Among patients with malignant HNPGLs, 5 (83%) were treated with adjuvant radiation, and 1 (17%) was treated with adjuvant chemotherapy. CONCLUSIONS AND RELEVANCE: Malignant HNPGLs are rare entities that are difficult to diagnose and are typically identified by the presence of regional or distant metastasis. The results of this study found the prevalence of malignant HNPGLs to be 9%. These data suggest that it is beneficial to perform a selective neck dissection at the time of tumor excision. All patients with malignant HNPGLs but 1 had SDHB mutations.
引用
- McCrary HC, Babajanian E, Calquin M, et al. Characterization of Malignant Head and Neck Paragangliomas at a Single Institution Across Multiple Decades. JAMA Otolaryngol Head Neck Surg. 2019. PMID: 31194233. doi:10.1001/jamaoto.2019.1110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。